EXCLUSIVE
Home visits are the key to patient retention, says ResearchNurses.co
Including home visits in clinical trial designs could be the key to patient retention, according to ResearchNurses.co.
Archives for May 29, 2012
Drop “outmoded” training to boost GMP compliance; study
Many biopharma firms can improve their GMP compliance efforts by dropping “outmoded” training measures, a report found.
FDA warns of fake Teva ADHD drug as shortage continues
The FDA has warned patients about counterfeit versions of a Teva ADHD drug that is on the drug shortage list.
Vertex shares plunge after mix up with data analysis vendor
Vertex shares plunged 10 per cent yesterday after a misunderstanding with its data analysis vendor led to it overstating results.
Cost cutting positions contract sales for growth in US; analyst
US contract sales and packaging services are underutilised but penetration is poised to grow as firms cut fixed costs, an analyst said.
News from Pfizer, EMD Millipore and Jubilant – People on the move
In-PharmaTechnologist presents its weekly round-up of the latest new appointments in the pharma biz, including news from Pfizer, EMD Millipore and Jubilant.
FDA's new User Fee Bill spurs hopes for safer overseas supply chain
The US drug industry has welcomed news that Senate has passed the FDA’s amended User Fee Reauthorization Bill in the hopes it will mean a safer global supply chain.